About Tune Therapeutics
Tune Therapeutics develops genetic tuning technology to control gene activity without altering DNA sequences. The company's TEMPO platform aims to address common, chronic, and age-related diseases. Tune Therapeutics is developing solutions for diseases and is conducting clinical trials for its therapies.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $175,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $40,000,000 · Series-A
- Milestone
X account created (@tunetx_news)
1.1K followers
- Milestone
Company founded
Durham, United States
- Milestone
Website domain registered
tunetx.com
Investors & Backers
Funding History
Founders & Leadership
Akira Matsuno
Co-Founder
Ben Scruggs
Sr. Director, Strategic Initiatives
Charles Gersbach
Co-Founder
Dan McHugh
Co-Founder, Investor
Derek Jantz
Chief Scientific Officer
Fyodor Urnov
Co-Founder
Heidi Zhang
Head of Tech Ops
Matthew Kane
Chief Executive Officer
Zachary Hale
EVP and General Counsel
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com